Tatarian, T., Jiang, W., Leiby, B. E., Grigoli, A., Jimbo, M., Dabbish, N., . . . Brody, J. R. (2018). Cytoplasmic HuR Status Predicts Disease-free Survival in Resected Pancreatic Cancer: A Post-hoc Analysis From the International Phase III ESPAC-3 Clinical Trial. Ann Surg.
Chicago Style CitationTatarian, Talar, et al. "Cytoplasmic HuR Status Predicts Disease-free Survival in Resected Pancreatic Cancer: A Post-hoc Analysis From the International Phase III ESPAC-3 Clinical Trial." Ann Surg 2018.
MLA CitationTatarian, Talar, et al. "Cytoplasmic HuR Status Predicts Disease-free Survival in Resected Pancreatic Cancer: A Post-hoc Analysis From the International Phase III ESPAC-3 Clinical Trial." Ann Surg 2018.
Warning: These citations may not always be 100% accurate.